Poster Sessions
24 September 2008
24 September 2008
24 September 2008
Alessandra Mangia, Angelo Andriulli – 28 August 2008
Jeffrey Campsen, Andres T. Blei, Jean C. Emond, James E. Everhart, Chris E. Freise, Anna S. Lok, Sammy Saab, Karen A. Wisniewski, James F. Trotter, Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study Group – 28 August 2008 – For acute liver failure (ALF), living donor liver transplantation (LDLT) may reduce waiting time and provide better timing compared to deceased donor liver transplantation (DDLT).
Michel Mendler, Hansen Kwok, Edson Franco, Pedro Baron, Jill Weissman, Okechukwu Ojogho – 28 August 2008 – Peripheral blood CD4+ adenosine triphosphate [ATP (ng/mL)] release [ImmuKnow Immune Cell Function Assay (ATP)] correlates to immunoreactivity. We hypothesized that ATP levels could provide insight into hepatitis C virus (HCV) infection and recurrent liver disease in liver transplantation (LT). We studied our center's LT cohort, in which ATP levels had been measured off protocol from February 2005 through July 2006.
Tetsuji Fujita – 28 August 2008
Federica Dondéro, Guido Liddo, Wellington Andraus, Daniele Sommacale, Alain Sauvanet, Jacques Belghiti – 28 August 2008
Marion Margaret Aw, Anita Verma, Mohamed Rela, Nigel Heaton, Giorgina Mieli‐Vergani, Anil Dhawan – 28 August 2008 – Mycophenolate mofetil (MMF) has been used to rescue liver allografts with steroid‐resistant rejection (SRR). However, the long‐term outcome of these patients is not known. This study evaluates the long‐term outcome of MMF rescue therapy for SRR in pediatric liver allograft recipients. Twenty‐six children (who received 28 liver transplants), including 16 girls, were given MMF for SRR. The median age at transplant was 1.7 (range 0.4‐13.6) years.
Hiroto Kayashima, Akinobu Taketomi, Yusuke Yonemura, Hideki Ijichi, Noboru Harada, Tomoharu Yoshizumi, Yuji Soejima, Kengo Yoshimitsu, Yoshihiko Maehara – 28 August 2008 – In living donor liver transplantation, the estimated graft volume (GV) from young donors tends to be overestimated. One reason for this error may be a decrease in GV due to dehydration by University of Wisconsin (UW) solution. The aim of this study was to clarify (1) the usefulness of an age‐adjusted formula and (2) the correlation between the decrease in GV and donor age.
Miquel Navasa, Xavier Forns – 28 August 2008